Capstone Wealth Management Group (Pennsylvania)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Capstone Wealth Management Group (Pennsylvania)'s AMGN Position: Q2 2026 in Review
Capstone Wealth Management Group (Pennsylvania) increased its Amgen (AMGN) stake by 0.63% in Q2 2026, buying an estimated $1.37K and bringing the position to 642 shares worth $232K. The position accounts for 0.08% of the portfolio, ranked #88.
Capstone Wealth Management Group (Pennsylvania) first reported a position in AMGN in Q4 2021 and has held it in 9 quarters since. The position peaked at $302K in Q1 2022. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Capstone Wealth Management Group (Pennsylvania) held 642 shares of Amgen worth $232K as of Q2 2026.
- Capstone Wealth Management Group (Pennsylvania) bought 4 Amgen shares in Q2 2026, an estimated $1.37K.
- Amgen made up 0.08% of Capstone Wealth Management Group (Pennsylvania)'s portfolio in Q2 2026, its #88 holding.
- Capstone Wealth Management Group (Pennsylvania) first reported a position in Amgen in Q4 2021 and has held it in 9 quarters since.
- Capstone Wealth Management Group (Pennsylvania)'s Amgen position peaked at $302K in Q1 2022.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Capstone Wealth Management Group (Pennsylvania)'s 13F filing for Q2 2026, filed 30 Jul 2026.